A recent study, in contrast, found that TRIM21/Ro52 inhibits the expression of the lipogenic enzyme via the degradation of sterol regulatory element binding transcription factor 1 (SREBF1), attenuating lipogenesis and tumor growth in renal cell carcinoma [50]. This evidence concerns the gene SREBF1 and renal cell carcinoma.